N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors
- 23 April 2003
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 65 (10) , 1675-1684
- https://doi.org/10.1016/s0006-2952(03)00153-9
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Synthesis, Biological Properties, and Molecular Modeling Investigation of the First Potent, Selective, and Water-Soluble Human A3 Adenosine Receptor AntagonistJournal of Medicinal Chemistry, 2002
- Identification by Site-directed Mutagenesis of Residues Involved in Ligand Recognition and Activation of the Human A3 Adenosine ReceptorJournal of Biological Chemistry, 2002
- 5‘-O-Alkyl Ethers of N,2-Substituted Adenosine Derivatives: Partial Agonists for the Adenosine A1 and A3 ReceptorsJournal of Medicinal Chemistry, 2001
- Agonist activity of 2- and 5′-substituted adenosine analogs and their N6-cycloalkyl derivatives at A1− and A2−adenosine receptors coupled to adenylate cyclaseBiochemical Pharmacology, 1992
- Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptorsJournal of Medicinal Chemistry, 1991
- N6-Substituted adenosine receptor agonists: potential antihypertensive agentsJournal of Medicinal Chemistry, 1991
- Structure-activity relationships for N6-substituted adenosines at a brain A1-adenosine receptor with a comparison to an A2-adenosine receptor regulating coronary blood flowBiochemical Pharmacology, 1986
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973